Skinvisible, Inc. (SKVI)

Skinvisible Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-1.16	-2.38	-2.21	-2.29	-2.64	-2.72
Depreciation & Amortization	0.02	0.02	0.02	0.02	0.03	0.04
Other Operating Activities	1.1	2.29	2.24	2.64	2.66	2.55
Operating Cash Flow	-0.04	-0.08	0.05	0.37	0.05	-0.13
Operating Cash Flow Growth	-	-	-87.94%	718.54%	-	-
Capital Expenditures	0	-0.01	-0	-0.02	-0.02	-0.03
Acquisitions	0	0	0	0	0	0.08
Other Investing Activities	-9,333	-	-	-	-	-
Investing Cash Flow	-9,333	-0.01	-0	-0.02	-0.02	0.05
Common Stock Issued	0	0	0	0	0	2,000,892
Other Financing Activities	0.03	0.01	-0.03	-0.32	0.01	-2,000,891.92
Financing Cash Flow	0.03	0.01	-0.03	-0.32	0.01	0.08
Net Cash Flow	-0.02	-0.08	0.02	0.03	0.03	-0
Free Cash Flow	-0.04	-0.09	0.04	0.35	0.03	-0.15
Free Cash Flow Growth	-	-	-87.95%	1119.88%	-	-
Free Cash Flow Margin	-186.04%	-432.44%	15.27%	53.32%	10.52%	-357.52%
Free Cash Flow Per Share	-0.01	-0.02	0.01	0.08	0.01	-0.05

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.